Client Management | Digital KYC | Transactions | Investor App | AUM & Brokerage Reports | Lead Management | Automated Follow-Ups | MF Research | Multi-Asset Tracking
Login
Get Started
Home Mf Research Bajaj Finserv Healthcare Fund Regular Plan Growth
Bajaj Finserv Mutual Fund

Mutual Fund Research

Bajaj Finserv Healthcare Fund - Regular Plan - Growth

Bajaj Finserv Mutual Fund Equity Equity Sectoral Thematic

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-28 ₹1,000.00 ₹1,034.47 +3.45%
Two Week 2026-10-21 ₹1,000.00 ₹1,084.67 +8.47%
One Month 2026-10-05 ₹1,000.00 ₹1,039.14 +3.91%
Three Months 2026-08-06 ₹3,000.00 ₹3,039.81 +1.33%
Six Months 2026-05-08 ₹6,000.00 ₹6,385.49 +6.42%
One Year 2025-11-04 ₹12,000.00 ₹13,834.79 +15.29%
Since Inception 2024-12-27 ₹23,000.00 ₹27,346.68 +18.90%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 73.73%
Healthcare Services 15.62%
Other 4.44%
Food Products 2.20%
Consumer Durables 1.88%
Chemicals & Petrochemicals 1.17%
Insurance 0.75%
Fertilizers & Agrochemicals 0.21%

Top Holdings

Company-wise portfolio exposure

Divi's Laboratories Limited 9.75%
Sun Pharmaceutical Industries Limited 8.96%
Piramal Pharma Limited 6.36%
Rubicon Research Limited 6.08%
Aurobindo Pharma Limited 6.03%
Apollo Hospitals Enterprise Limited 5.51%
Torrent Pharmaceuticals Limited 4.78%
Emcure Pharmaceuticals Limited 4.03%
Laurus Labs Limited 3.91%
Neuland Laboratories Limited 3.82%
Max Healthcare Institute Limited 2.99%
Alkem Laboratories Limited 2.96%
Zydus Lifesciences Limited 2.57%
IPCA Laboratories Limited 2.40%
Fortis Healthcare Limited 2.28%
Zydus Wellness Limited 2.20%
Vijaya Diagnostic Centre Limited 2.19%
Senores Pharmaceuticals Limited 2.08%
Shaily Engineering Plastics Limited 1.88%
Dr. Lal Path Labs Limited 1.73%
GlaxoSmithKline Pharmaceuticals Limited 1.63%
Glenmark Pharmaceuticals Limited 1.60%
Dr. Reddy's Laboratories Limited 1.37%
Cipla Limited 1.33%
Sanofi Consumer Healthcare India Limited 1.30%
Biocon Limited 1.05%
Navin Fluorine International Limited 0.94%
Krishna Institute Of Medical Sciences Limited 0.92%
Jubilant Pharmova Limited 0.89%
Onesource Specialty Pharma Limited 0.83%
Medi Assist Healthcare Services Limited 0.75%
Neogen Chemicals Limited 0.23%
Sumitomo Chemical India Limited 0.21%
Bajaj Finserv Money Market Fund-Direct Plan-Growth 1.31%
Clearing Corporation of India Ltd 2.32%
Net Receivables / (Payables) 0.81%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
13.40%
Return volatility
β
Beta
0.86
Benchmark sensitivity
S
Sharpe Ratio
0.22
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Peer Comparison

Compare similar mutual funds by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
Nippon India Taiwan Equity Fund - Regular Plan - Growth 59.11% 48.18% 22.89%
HDFC Pharma And Healthcare Fund - Regular Plan - Growth 22.21% 29.08% 28.07%
Kotak Healthcare Fund - Regular Plan - Growth 21.83% 0.00% 19.25%
ICICI Prudential US Bluechip Equity Fund - Regular Plan - Growth 20.30% 18.34% 15.87%
Nippon India - Japan Equity Fund - Regular Plan - Growth 20.05% 20.38% 8.48%
SBI Automotive Opportunities Fund - Regular Plan - Growth 18.72% 0.00% 10.86%
Mirae Asset Healthcare Fund - Regular Plan - Growth 17.38% 22.11% 20.05%
Whiteoak Capital - Pharma And Healthcare Fund - Regular Plan - Growth 17.07% 0.00% 20.11%
SBI Healthcare Opportunities Fund - Regular Plan - Growth 16.50% 23.22% 15.44%
PGIM India Healthcare Fund - Regular Plan - Growth 16.27% 0.00% 9.01%

Returns are historical and do not guarantee future performance.

View All Equity Sectoral Thematic Funds

Fund Family

Compare schemes from Bajaj Finserv Mutual Fund by performance, fundamentals and risk.

Fund Name 1Y Return 3Y Return Since Inception
Bajaj Finserv Healthcare Fund - Regular Plan - Growth 16.66% 0.00% 8.50%
Bajaj Finserv Small Cap Fund - Regular Plan - Growth 6.40% 0.00% 4.61%
Bajaj Finserv Liquid Fund - Regular Plan - Growth 6.27% 6.72% 6.73%
Bajaj Finserv Arbitrage Fund - Regular Plan - Growth 6.04% 6.27% 6.31%
Bajaj Finserv Money Market Fund - Regular Plan - Growth 5.66% 6.64% 6.74%
Bajaj Finserv Overnight Fund - Regular Plan - Growth 5.29% 5.98% 6.06%
Bajaj Finserv Nifty 1D Rate Liquid ETF - Regular Plan - Growth 4.84% 0.00% 4.22%
Bajaj Finserv GILT Fund - Regular Plan - Growth 3.44% 0.00% 3.50%
Bajaj Finserv Banking And PSU Debt Fund - Regular Plan - Growth 3.29% 0.00% 6.46%
Bajaj Finserv Equity Savings Fund - Regular Plan - Growth 3.11% 0.00% 3.32%

Returns are historical and do not guarantee future performance.

View All Bajaj Finserv Mutual Fund Funds

Scheme Objective

The investment mandate and purpose of this scheme

An open ended equity scheme investing in pharma, healthcare and allied theme.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
2.59%
Expense Ratio (Direct)
0.90%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare TRI

Exit Load

Charges that may apply when you redeem units

For each purchase of units through Lumpsum / switch-in / Systematic Investment Plan (SIP) and Systematic Transfer Plan (STP), exit load will be as follows: • if units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV. • if units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable.
Top AMC/Fund Houses
360 ONE Mutual Fund AMC logo
360 ONE Mutual Fund
AUM
₹13,053 Cr
Age
15+ Years
Aditya Birla Sun Life Mutual Fund AMC logo
Aditya Birla Sun Life Mutual Fund
AUM
₹4.36 Lakh Cr
Age
31+ Years
Helios Mutual Fund AMC logo
Helios Mutual Fund
AUM
₹9,401 Cr
Age
1–2 Years
Bandhan Mutual Fund AMC logo
Bandhan Mutual Fund
AUM
₹1.78+ Lakh Cr
Age
4 Years
view all

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?